BioAgilytix Acquires IPM Biotech

BioAgilytix, a provider of contract bioanalytical testing services specializing in large molecule bioanalysis, said today it has acquired IPM Biotech for an undisclosed price. BioAgilytix said the deal will combine IPM’s immunogenicity, pharmacokinetics (PK), and pharmacodynamics (PD) expertise with BioAgilytix’s complementary capabilities in immunogenicity and PK, as well as biomarkers and cell-based assays.

Click for full article
Share This

Other Podcasts

Molecular Moments Episode 2 Banner
Welcome to episode one of the Molecular Moments podcast! On this first episode, Dr. Chad Briscoe is joined by his guest, Ph.D scientist, Dr. Jim McNally, and they get down to business as the two explore the various nuances in the outstanding work of McNally, how his career in bioanalysis became personal in an unexpected…
Molecular Moments Episode 2 Banner
In today’s episode, Dr. Chad Briscoe sits down with guest scientist and biomarker expert, Dr. Marianne Fjording (Scientific Officer, BioAgilytix). Marianne and Chad discuss her expertise in biomarkers and EU bioanalysis- including how Denmark became a scientific hub and what fit-for-purpose really means. They also dive into Marianne’s jump from pharma to CRO, a family…